JONATHAN ZALEVSKY, PH.D.

Corporate Board Profile

Tech Score: 100/100

← Back to All Directors

Software Technology Evidence

1 mention(s) identify JONATHAN ZALEVSKY, PH.D. as having software/technology expertise.

Company Filing Date Evidence Reason
NEKTAR THERAPEUTICS 2021-04-30 Jonathan Zalevsky, Ph.D., Chief Research and Development Officer. Holds a Ph.D. and is Chief Research and Development Officer, indicating a technical background likely including software or scientific programming skills.

NEKTAR THERAPEUTICS

Filing Date Source Excerpt
2021-04-30 Jonathan Zalevsky, Ph.D., Chief Research and Development Officer.

Data sourced from SEC filings. Last updated: 2025-10-11